FR2189023A1 - - Google Patents
Info
- Publication number
- FR2189023A1 FR2189023A1 FR7319343A FR7319343A FR2189023A1 FR 2189023 A1 FR2189023 A1 FR 2189023A1 FR 7319343 A FR7319343 A FR 7319343A FR 7319343 A FR7319343 A FR 7319343A FR 2189023 A1 FR2189023 A1 FR 2189023A1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/175—Canine distemper virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- G—PHYSICS
- G10—MUSICAL INSTRUMENTS; ACOUSTICS
- G10L—SPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING
- G10L15/00—Speech recognition
- G10L15/22—Procedures used during a speech recognition process, e.g. man-machine dialogue
- G10L2015/226—Procedures used during a speech recognition process, e.g. man-machine dialogue using non-speech characteristics
- G10L2015/227—Procedures used during a speech recognition process, e.g. man-machine dialogue using non-speech characteristics of the speaker; Human-factor methodology
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2225548A DE2225548C3 (de) | 1972-05-26 | 1972-05-26 | Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2189023A1 true FR2189023A1 (en:Method) | 1974-01-25 |
| FR2189023B1 FR2189023B1 (en:Method) | 1976-12-03 |
Family
ID=5845894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7319343A Expired FR2189023B1 (en:Method) | 1972-05-26 | 1973-05-28 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3886270A (en:Method) |
| AR (1) | AR201193A1 (en:Method) |
| AT (1) | AT336779B (en:Method) |
| AU (1) | AU467451B2 (en:Method) |
| BE (1) | BE800132A (en:Method) |
| CA (1) | CA1020461A (en:Method) |
| DE (1) | DE2225548C3 (en:Method) |
| DK (1) | DK141055C (en:Method) |
| FR (1) | FR2189023B1 (en:Method) |
| GB (1) | GB1437006A (en:Method) |
| NL (1) | NL163428C (en:Method) |
| SE (1) | SE7608007L (en:Method) |
| ZA (1) | ZA733571B (en:Method) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL133476B1 (en) * | 1981-06-10 | 1985-06-29 | Akad Medyczna | Method of obtaining pure antigen hba from human serum |
| US5000951A (en) * | 1987-03-09 | 1991-03-19 | Diamond Scientific Company | Multivalent canine distemper virus vaccine |
| US4990367A (en) * | 1987-03-09 | 1991-02-05 | Diamond Scientific Company | Canine distemper virus vaccine |
| CN105884889A (zh) * | 2016-04-18 | 2016-08-24 | 内蒙古神元生物工程股份有限公司 | 犬瘟热-传染性肝炎-细小病毒三联卵黄抗体及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3470294A (en) * | 1961-06-21 | 1969-09-30 | Behringwerke Ag | Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it |
| US3316153A (en) * | 1965-03-29 | 1967-04-25 | Lilly Co Eli | Virus purification |
| US3519400A (en) * | 1967-01-25 | 1970-07-07 | Atomic Energy Commission | Method of centrifugal separation and recovery of chemical species utilizing a liquid medium |
-
1972
- 1972-05-26 DE DE2225548A patent/DE2225548C3/de not_active Expired
-
1973
- 1973-05-18 NL NL7306986.A patent/NL163428C/xx not_active IP Right Cessation
- 1973-05-23 AR AR248179A patent/AR201193A1/es active
- 1973-05-24 CA CA172,332A patent/CA1020461A/en not_active Expired
- 1973-05-24 US US363413A patent/US3886270A/en not_active Expired - Lifetime
- 1973-05-25 AU AU56125/73A patent/AU467451B2/en not_active Expired
- 1973-05-25 ZA ZA733571A patent/ZA733571B/xx unknown
- 1973-05-25 DK DK291173A patent/DK141055C/da not_active IP Right Cessation
- 1973-05-25 AT AT459273A patent/AT336779B/de not_active IP Right Cessation
- 1973-05-28 BE BE131601A patent/BE800132A/xx not_active IP Right Cessation
- 1973-05-28 FR FR7319343A patent/FR2189023B1/fr not_active Expired
- 1973-05-29 GB GB2551673A patent/GB1437006A/en not_active Expired
-
1976
- 1976-07-13 SE SE7608007A patent/SE7608007L/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AT336779B (de) | 1977-05-25 |
| ZA733571B (en) | 1974-04-24 |
| FR2189023B1 (en:Method) | 1976-12-03 |
| DE2225548A1 (de) | 1973-12-06 |
| AR201193A1 (es) | 1975-02-21 |
| CA1020461A (en) | 1977-11-08 |
| GB1437006A (en) | 1976-05-26 |
| NL163428B (nl) | 1980-04-15 |
| NL7306986A (en:Method) | 1973-11-28 |
| DK141055B (da) | 1979-12-31 |
| AU5612573A (en) | 1974-11-28 |
| DE2225548B2 (de) | 1979-09-06 |
| DK141055C (da) | 1980-06-23 |
| AU467451B2 (en) | 1975-12-04 |
| DE2225548C3 (de) | 1980-05-29 |
| NL163428C (nl) | 1980-09-15 |
| SE7608007L (sv) | 1976-07-13 |
| ATA459273A (de) | 1976-09-15 |
| BE800132A (fr) | 1973-11-28 |
| US3886270A (en) | 1975-05-27 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CL | Concession to grant licences | ||
| ST | Notification of lapse |